PMC Links for Books (Select 5109638) - PMC

Links from Books

Items: 1 to 20 of 24

<< First< Prev

Page of 2

Select item 84625931.

Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)

Scott Kopetz, Katherine A. Guthrie, Van K. Morris, Heinz-Josef Lenz, Anthony M. Magliocco, Dipen Maru, Yibing Yan, Richard Lanman, Ganiraju Manyam, David S. Hong, Alexey Sorokin, Chloe E. Atreya, Luis A. Diaz, Carmen Allegra, Kanwal P. Raghav, Stephen E. Wang, Christopher H. Lieu, Shannon L. McDonough, Philip A. Philip, Howard S. Hochster

J Clin Oncol. 2021 Feb 1; 39(4): 285–294. Published online 2020 Dec 23. doi: 10.1200/JCO.20.01994

PMCID:: PMC8462593

Article PDF–554K

Select item 75051212.

Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer Retrospective Analyses of the CRYSTAL and FIRE-3 Trials

Sabine Tejpar, Sebastian Stintzing, Fortunato Ciardiello, Josep Tabernero, Eric Van Cutsem, Frank Beier, Regina Esser, Heinz-Josef Lenz, Volker Heinemann

JAMA Oncol. Author manuscript; available in PMC 2020 Sep 21.

Published in final edited form as: JAMA Oncol. 2017 Feb 1; 3(2): 194–201. doi: 10.1001/jamaoncol.2016.3797

PMCID:: PMC7505121

Article PDF–615K

Select item 74978463.

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer

Yu Sunakawa, Kaoru Mogushi, Heinz-Josef Lenz, Wu Zhang, Akihito Tsuji, Takehiro Takahashi, Tadamichi Denda, Ken Shimada, Mitsugu Kochi, Masato Nakamura, Masahito Kotaka, Yoshihiko Segawa, Hiroaki Tanioka, Yuji Negoro, Miriana Moran, Stephanie H. Astrow, Jack Hsiang, Craig Stephens, Masashi Fujii, Wataru Ichikawa

Mol Cancer Ther. Author manuscript; available in PMC 2020 Sep 17.

Published in final edited form as: Mol Cancer Ther. 2018 Dec; 17(12): 2788–2795. Published online 2018 Oct 1. doi: 10.1158/1535-7163.MCT-18-0694

PMCID:: PMC7497846

Article PDF–917K

Select item 73706994.

Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study

Eric Van Cutsem, Sanne Huijberts, Axel Grothey, Rona Yaeger, Pieter-Jan Cuyle, Elena Elez, Marwan Fakih, Clara Montagut, Marc Peeters, Takayuki Yoshino, Harpreet Wasan, Jayesh Desai, Fortunato Ciardiello, Ashwin Gollerkeri, Janna Christy-Bittel, Kati Maharry, Victor Sandor, Jan H.M. Schellens, Scott Kopetz, Josep Tabernero

J Clin Oncol. 2019 Jun 10; 37(17): 1460–1469. Published online 2019 Mar 20. doi: 10.1200/JCO.18.02459

PMCID:: PMC7370699

Article PDF–875K

Select item 73095905.

Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)

Ankur Bahl, Vineet Talwar, Bhawna Sirohi, Prashant Mehta, Devavrat Arya, Gunjan Shrivastava, Akhil Dahiya, K. Pavithran

Front Oncol. 2020; 10: 964. Published online 2020 Jun 16. doi: 10.3389/fonc.2020.00964

PMCID:: PMC7309590

Article PDF–271K

Select item 72605826.

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer

Giandomenico Roviello, Alberto D'Angelo, Roberto Petrioli, Franco Roviello, Fabio Cianchi, Stefania Nobili, Enrico Mini, Daniele Lavacchi

Transl Oncol. 2020 Sep; 13(9): 100795. Published online 2020 May 26. doi: 10.1016/j.tranon.2020.100795

PMCID:: PMC7260582

Article PDF–651K

Select item 69969177.

Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study

Henri Montaudié, Julien Viotti, Patrick Combemale, Caroline Dutriaux, Nicolas Dupin, Caroline Robert, Laurent Mortier, Régis Kaphan, Anne-Bénédicte Duval-Modeste, Stéphane Dalle, Julie De Quatrebarbes, Andrea Stefan, Florence Brunet-Possenti, Maria Kogay, Alexandra Picard-Gauci, Gilles Poissonnet, Frédéric Peyrade

Oncotarget. 2020 Jan 28; 11(4): 378–385. Published online 2020 Jan 28. doi: 10.18632/oncotarget.27434

PMCID:: PMC6996917

Article PDF–1.5M

Select item 67782918.

Molecular Profiling of EGFR Status to Identify Skin Toxicity in Colorectal Cancer: A Clinicopathological Review

CM POPA, C LUNGULESCU, SL IANOȘI, I CHERCIU, M SCHENKER, A SĂFTOIU

Curr Health Sci J. 2019 Apr-Jun; 45(2): 127–133. Published online 2019 Jun 30. doi: 10.12865/CHSJ.45.02.01

PMCID:: PMC6778291

Article

Select item 67651609.

KRAS, NRAS, BRAF, HER2 and Microsatellite Instability in Metastatic Colorectal Cancer – Practical Implications for the Clinician

Vlad-Adrian Afrăsânie, Mihai Vasile Marinca, Teodora Alexa-Stratulat, Bogdan Gafton, Marius Păduraru, Anca Maria Adavidoaiei, Lucian Miron, Cristina Rusu

Radiol Oncol. 2019 Sep; 53(3): 265–274. Published online 2019 Sep 24. doi: 10.2478/raon-2019-0033

PMCID:: PMC6765160

Article PDF–591K

Select item 674582410.

The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta‐analysis of patient and study characteristics

Lauren C. Bylsma, Rebecca Dean, Kimberly Lowe, Laura Sangaré, Dominik D. Alexander, Jon P. Fryzek

Cancer Med. 2019 Sep; 8(12): 5800–5809. Published online 2019 Aug 3. doi: 10.1002/cam4.2413

PMCID:: PMC6745824

Article PDF–874K

Select item 613546611.

RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine

Anna M. Valentini, Elisabetta Cavalcanti, Marianna Di Maggio, Maria L. Caruso

Appl Immunohistochem Mol Morphol. 2018 Sep; 26(8): 539–544. Published online 2017 Jan 2. doi: 10.1097/PAI.0000000000000475

PMCID:: PMC6135466

Article PDF–292K

Select item 606991012.

High incidence of cetuximab-related infusion reactions in head and neck patients

Virginia Palomar Coloma, Pamela Bravo, Naima Lezghed, Lamia Mayache-Badis, Ruth Gabriela Herrera Gómez, Mariana Iacob, Laurence Nicouleau, Romain Desmaris, Yungan Tao, Cristian Leibu, Margarida Matias, Francois Lemare, Caroline Even, Maxime Annereau, Charles Ferté

ESMO Open. 2018; 3(5): e000346. Published online 2018 Jul 23. doi: 10.1136/esmoopen-2018-000346

PMCID:: PMC6069910

Article PDF–504K

Select item 595064813.

Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer

Richard M Goldberg, Clara Montagut, Zev A Wainberg, Philippe Ronga, François Audhuy, Julien Taieb, Sebastian Stintzing, Salvatore Siena, Daniele Santini

ESMO Open. 2018; 3(4): e000353. Published online 2018 May 5. doi: 10.1136/esmoopen-2018-000353

PMCID:: PMC5950648

Article PDF–1.2M

Select item 594353214.

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis

Alessandro Ottaiano, Alfonso De Stefano, Monica Capozzi, Anna Nappi, Chiara De Divitiis, Carmela Romano, Lucrezia Silvestro, Antonino Cassata, Rossana Casaretti, Salvatore Tafuto, Michele Caraglia, Massimiliano Berretta, Guglielmo Nasti, Antonio Avallone

Front Pharmacol. 2018; 9: 441. Published online 2018 May 3. doi: 10.3389/fphar.2018.00441

PMCID:: PMC5943532

Article PDF–2.2M

Select item 583361815.

Association of Primary Tumor Site With Mortality in Patients Receiving Bevacizumab and Cetuximab for Metastatic Colorectal Cancer

Mayada A. Aljehani, John W. Morgan, Laurel A. Guthrie, Brice Jabo, Majed Ramadan, Khaled Bahjri, Sharon S. Lum, Matthew Selleck, Mark E. Reeves, Carlos Garberoglio, Maheswari Senthil

JAMA Surg. 2018 Jan; 153(1): 60–67. Published online 2017 Sep 20. doi: 10.1001/jamasurg.2017.3466

PMCID:: PMC5833618

Article

Select item 568045716.

Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study

Eiji Shinozaki, Takayuki Yoshino, Kentaro Yamazaki, Kei Muro, Kensei Yamaguchi, Tomohiro Nishina, Satoshi Yuki, Kohei Shitara, Hideaki Bando, Sachiyo Mimaki, Chikako Nakai, Koutatsu Matsushima, Yutaka Suzuki, Kiwamu Akagi, Takeharu Yamanaka, Shogo Nomura, Satoshi Fujii, Hiroyasu Esumi, Masaya Sugiyama, Nao Nishida, Masashi Mizokami, Yasuhiro Koh, Yukiko Abe, Atsushi Ohtsu, Katsuya Tsuchihara

Br J Cancer. 2017 Nov 7; 117(10): 1450–1458. Published online 2017 Oct 3. doi: 10.1038/bjc.2017.308

PMCID:: PMC5680457

Article PDF–523K

Select item 553601217.

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment

Alessia Bignucolo, Elena De Mattia, Erika Cecchin, Rossana Roncato, Giuseppe Toffoli

Int J Mol Sci. 2017 Jul; 18(7): 1522. Published online 2017 Jul 14. doi: 10.3390/ijms18071522

PMCID:: PMC5536012

Article PDF–878K

Select item 467322918.

Markus Morkel, Pamela Riemer, Hendrik Bläker, Christine Sers

Oncotarget. 2015 Aug 28; 6(25): 20785–20800. Published online 2015 Jul 30. doi: 10.18632/oncotarget.4750

PMCID:: PMC4673229

Article PDF–1.8M

Select item 436759019.

Cetuximab in non-small-cell lung cancer

Robert Pirker, Martin Filipits

Transl Lung Cancer Res. 2012 Mar; 1(1): 54–60. doi: 10.3978/j.issn.2218-6751.11.01

PMCID:: PMC4367590

Article PDF–147K

Select item 396656420.

PharmGKB Summary: Very Important Pharmacogene Information for Epidermal Growth Factor Receptor (EGFR)

Ugur Hodoglugil, Michelle W. Carrillo, Joan M. Hebert, Niki Karachaliou, Rafael C. Rosell, Russ B. Altman, Teri E. Klein

Pharmacogenet Genomics. Author manuscript; available in PMC 2014 Mar 26.

Published in final edited form as: Pharmacogenet Genomics. 2013 Nov; 23(11): 636–642. doi: 10.1097/FPC.0b013e3283655091

PMCID:: PMC3966564

Article PDF–53K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 1 to 20 of 24

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity